Baskadia

To produce PET Nuclear Medicine  global market research report, the data is collected from the diverse corners of the globe by an experienced team of language resources. Strategic aspects of the ABC industry such as product development and specification, technology, niche growth opportunities, application modelling, and new geographical markets can be tackled with the vast information and data included in this report. This global market report gives CAGR value fluctuation during the forecast period of 2018-2025 for the market that helps in estimating investment and costing. Multifarious market insights are made simpler and then embodied in the PET Nuclear Medicine  report for the better understanding of end user. 

Data Bridge Market Research analyses that the positron emission tomography (PET) nuclear medicine market which was USD 9 billion in 2021, is expected to reach USD 27.53 billion by 2029, at a CAGR of 15% during the forecast period 2022 to 2029.

Download Exclusive Sample (350 Pages PDF) Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pet-nuclear-medicine-market

Market Definition

Positron emission tomography (PET) is a nuclear medicine procedure that measures the metabolic activity of body tissue cells. PET is a hybrid of nuclear medicine and biochemical analysis. PET is primarily used in patients with brain or heart conditions, as well as cancer, to visualize biochemical changes in the body, such as the heart muscle's metabolism (the process by which cells convert food into energy after food is digested/absorbed into the blood).

Global Positron Emission Tomography (PET) Nuclear Medicine Market Dynamics

Drivers

Rising demand of nuclear medicines in radiopharmaceutical applications

Nuclear medicine is used to detect heart disease and cancer. As these industries developed, some companies and investors focused on expanding radiopharmaceuticals' use. The expansion of radiopharmaceutical applications can boost demand and acceptance during the forecast period.

Growing demand of nuclear medicine diagnostics

The nuclear medicines diagnostics are mainly used in cancer treatment, such as in radiotherapy. According to GLOBOCAN 2021, 19.3 million new cancer cases were diagnosed worldwide in 2020, with the number expected to rise to 30.2 million cases by 2040. Furthermore, other factors, such as increasing SPECT and PET applications and growing public awareness of healthcare, are expected to drive the market during the forecast period.

Some of the major players operating in the positron emission tomography (PET) nuclear medicine market are:

Cardinal Health (U.S.)

General Electric (U.S.)

Lantheus (U.S.)

Bayer AG (Germany)

Bracco Diagnostic Inc. (Italy)

NorthStar Medical Radioisotopes, LLC (U.S.)

Eckert & Ziegler. (Germany)

Jubilant DraxImage, Inc. (Canada)

PharmaLogic Holdings Corp. (U.S.)

Institute of Isotopes Co., Ltd (Hungary)

SHINE Medical Technologies, LLC (U.S.)

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global PET Nuclear Medicine  Market Landscape

Part 04: Global PET Nuclear Medicine  Market Sizing

Part 05: Global PET Nuclear Medicine  Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Browse Full Report Along With Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-pet-nuclear-medicine-market

Get Latest TOC of This Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-pet-nuclear-medicine-market

Related reports:

https://www.databridgemarketresearch.com/reports/global-enhanced-ambulatory-patient-grouping-software-market

https://www.databridgemarketresearch.com/reports/global-gout-therapeutics-market

https://www.databridgemarketresearch.com/reports/global-third-generation-ventricular-assist-devices-market

https://www.databridgemarketresearch.com/reports/global-ethylenediaminetetraacetic-acid-edta-tubes-market

https://www.databridgemarketresearch.com/reports/global-status-epilepticus-treatment-market

https://www.databridgemarketresearch.com/reports/global-ready-to-use-disinfectant-in-personal-use-market

About Data Bridge Market Research:

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

Contact Us: -

Data Bridge Market Research

US: +1 888 387 2818

United Kingdom: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: – [email protected]